These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28029398)

  • 1. Re: Marco Borghesi, Hashim Ahmed, Robert Nam, et al. Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol 2017;71:353-65.
    Grummet J; Pepdjonovic L; Moon D
    Eur Urol; 2017 May; 71(5):e143-e144. PubMed ID: 28029398
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: M. Minhaj Siddiqui, Soroush Rais-Bahrami, Hong Truong, et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013;64:713-9 and Re: Mark Emberton. Has magnetic resonance-guided biopsy of the prostate become the standard of care? Eur Urol 2013;64:720-1.
    van den Bergh RC; van der Poel HG
    Eur Urol; 2014 Jun; 65(6):e106-7. PubMed ID: 24411989
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Hashim U. Ahmed, Louise Dickinson, Susan Charman, et al. Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study. Eur Urol 2015;68:927-36.
    Li H; Yan W; Ji Z
    Eur Urol; 2016 Nov; 70(5):e131. PubMed ID: 27085626
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56.
    Zhou Y; Yan W; Li H
    Eur Urol; 2016 Aug; 70(2):e53-4. PubMed ID: 26838479
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Yaalini Shanmugabavan, Stephanie Guillaumier and Hashim U. Ahmed's letter to the editor re: Morgan R. Pokorny, Maarten de Rooij, Earl Duncan, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 2014;66:22-9.
    Pokorny M; Van de Ven W; Barentsz J; Thompson L
    Eur Urol; 2015 Mar; 67(3):e54-5. PubMed ID: 25194908
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56.
    Baco E; Rud E; Vlatkovic L
    Eur Urol; 2016 Aug; 70(2):e55. PubMed ID: 26852076
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy.
    Evangelista L; Lopci E
    Eur Urol; 2021 Jul; 80(1):e24-e27. PubMed ID: 33947593
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Benjamin S. Simpson, Lina M. Carmona Echeverria, Joseph M. Norris, Hashim U. Ahmed, Caroline M. Moore, and Hayley C. Whitaker's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7.
    Chesnut GT; Vickers AJ; Ehdaie B
    Eur Urol; 2020 Sep; 78(3):e108-e109. PubMed ID: 32522388
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy.
    Van Poppel H; Hogenhout R; Albers P; van den Bergh RCN; Barentsz JO; Roobol MJ
    Eur Urol; 2021 Jul; 80(1):e28-e29. PubMed ID: 33965287
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply from authors re: Hebert Alberto Vargas, Hedvig Hricak. Magnetic resonance imaging-targeted prostate biopsies: now is the time to START. Eur Urol 2013;64:553-4: START: the beginning of a multidisciplinary effort to define the role of MRI-targeted Biopsy in the detection of clinically significant prostate cancer.
    Moore CM; Kasivisvanathan V;
    Eur Urol; 2013 Oct; 64(4):555-6. PubMed ID: 23856040
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply from authors re: Francesco Montorsi, Giorgio Gandaglia. Sentinel node biopsy for prostate cancer: a useless surgical exercise? Eur urol 2014;66:999-1000: Removing nodes that count rather than counting nodes that don't.
    van der Poel HG; van den Berg NS; KleinJan GH; van Leeuwen FW
    Eur Urol; 2014 Dec; 66(6):1000-1. PubMed ID: 25440526
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Thomas Hambrock, Caroline Hoeks, Christina Hulsbergen-van de Kaa, et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 2012;61:177-84.
    Ponholzer A; Madersbacher S
    Eur Urol; 2012 May; 61(5):e52. PubMed ID: 22365282
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.
    van der Poel HG; van den Bergh RCN; Briers E; Cornford P; Govorov A; Henry AM; Lam TB; Mason MD; Rouvière O; De Santis M; Wiegel T; Willemse PM; van Poppel H; Mottet N
    Eur Urol; 2019 Feb; 75(2):e23-e24. PubMed ID: 30237024
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Lyndon Gommersall, Iqbal S. Shergill, Hashim U. Ahmed et al. Nanotechnology and its relevance to the urologist. Eur Urol 2007;52:368-75.
    Johannsen M; Jordan A; Wust P; Loening SA
    Eur Urol; 2008 Apr; 53(4):860. PubMed ID: 17954008
    [No Abstract]   [Full Text] [Related]  

  • 15. Viscosity as a Biomarker Coincident with Shear Wave Elastography. Re: Prediction of Significant Prostate Cancer at Prostate Biopsy and Per Core Detection Rate of Targeted and Systematic Biopsies Using Real-Time Shear Wave Elastography (Urol Int 2015; DOI: 10.1159/000431233).
    Ozel D; Duran Ozel B; Ozkan F
    Urol Int; 2016; 96(1):122. PubMed ID: 26645276
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol 2019;76:284-303.
    Montorsi F; Gandaglia G; Briganti A
    Eur Urol; 2019 Nov; 76(5):e132. PubMed ID: 31400947
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.
    Boscolo-Berto R; Galfano A; Iafrate M
    Eur Urol; 2008 Aug; 54(2):469-70; author reply 471. PubMed ID: 18299171
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy: A. ElShafei, Y. Nyame, O. Kara, A. Badawy, I. Amujiogu, K. Fareed, E. Klein and J. S. Jones J Urol 2016;195:1767-1772.
    Ji Z; Yan W; Chen J
    J Urol; 2016 Nov; 196(5):1590-1591. PubMed ID: 27479525
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Oberlin et al.: Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate (Urology 2016;92:75-79).
    Erbin A; Ozdemir H; Binbay M
    Urology; 2017 Dec; 110():266-267. PubMed ID: 28847693
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Marco Borghesi, Gaetano La Manna, and Riccardo Schiavina's Letter to the Editor re: Sabine D. Brookman-May, Matthias May, Ingmar Wolff, et al. Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1-pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA Project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? Eur Urol 2015;67:943-51.
    Brookman-May S; Shariat SF; May M
    Eur Urol; 2016 May; 69(5):e101-2. PubMed ID: 26388502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.